Serum Magnesium Level Change in Type 2 Diabetic Patients with Cardiovascular Complications | ||||
| The Medical Journal of Cairo University | ||||
| Article 50, Volume 87, September, September 2019, Page 3137-3145 PDF (774.56 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjcu.2019.59517 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| MOHAMMED ELGAZZAR, M.Sc.; ABD ELMOTTALEB TAHA EISSA, M.D.; AMAL SAID ALBENDARY, M.D.; YASSER MOHAMED ABDELRAOUF, M.D. | ||||
| The Department of Internal Medicine, Faculty of Medicine, Tanta University, Egypt | ||||
| Abstract | ||||
| Abstract Background: Diabetic macrovascular complications remain the main cause of morbidity and mortality in type 2 diabetes patients. Magnesium is a necessary cofactor for several enzymes that play an important role in glucose metabolism. Aim of Study: This work was designed to investigate the relation between serum magnesium and diabetic cardiovascular complications. Patients and Methods: In the present study, 120 patients with type 2 diabetes mellitus were enrolled from Internal Medicine Diabetes and Endocrine Unit Out-patient Clinic, Tanta University Hospitals, Egypt, and 30 individuals as a control within a period of one year. The enrolled individuals were divided into two groups. Group I included 30 healthy non diabetic individuals as control group. Group II included 120 type 2 diabetes patients classified into subgroups; A-30 type 2 diabetic patients without any vascular com-plications. B-30 type 2 diabetic patients with ischemic heart disease. C-30 type 2 diabetic patients with nephropathy. D-30 type 2 diabetic patients with retinopathy. Serum magnesium and other investigations were taken to evaluate the relation between serum magnesium and diabetic macrovascular complications. Result: Serum magnesium level was significantly low in patients with ischemic heart disease 1.28±0.36mg/dl. It was found using recipient characteristic observer curve for mag-nesium as a predictor of diabetic complications that serum magnesium level of 0.9mg/dl was accompanied with 76.4% sensitivity and 72% specificity for prediction of complications. While, HbA1C 7.5% was accompanied with 86.1% sensitivity and 46.2% specificity for prediction of macrovascular com-pilations. Serum magnesium level could be a predictor of occurrence of diabetic complications, but its role in pathogen-esis cannot be well stated as our data did not confirm that hypomagnesaemia is an independent risk factor for diabetes complications. Conclusion: From this study, it can be concluded that that serum magnesium level could be a predictor of occurrence of diabetic complications, but its role in pathogenesis cannot be well stated as our data did not confirm that hypomagnesaemia is an independent risk factor for diabetes complications. | ||||
| Keywords | ||||
| Serum magnesium; Diabetic patients type 2; Cardiovascular complications | ||||
|
Statistics Article View: 302 PDF Download: 198 |
||||
